Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
--------
Question: Paragraph: We give the story credit for at least citing a $30,000 cost for the "surgeries" but wish it had explained what that included and what it might not. Surgery to change the battery every two years certainly adds to cost. Undoubtedly patients require more intensive expensive followup and perhaps specialized checks to ensure the device is working. With broad strokes across discussion of three different uses for three different conditions, the story did an adequate job quantifiying benefits. As stated in the "Evidence" criterion above, this is where a control group and reporting response rates for treated versus control groups would be very informative. Instead, we only get a qualitative description of benefits which is useful but which might leave careful readers asking for more. This is one area where the story could have been improved. There was no detailed discussion of what can go wrong with deep brain stimulation. There was a brief mention of "if" the electrodes cause neurological side effects. But how often does that happen? And the story noted that the surgery does "sometimes" cause dangerous brain bleeding or infections. How often is "sometimes"? At a very high, overview level, the story explained the current state of the evidence. But more information would have been better. Current evidence for depression/OCD is based on case series. These studies don't have a control group, making the results more subject to bias. No disease mongering of any of the conditions discussed. The story was repeatedly clear about deep brain stimulation being used when standard medications or behavior therapy had not worked. But it would be helpful to give estimates of the proportion of patients with depression or OCD who aren't helped by available treatments. Several sources were cited. Dr. Mayberg's connection to St. Jude Medical was mentioned. The story could have mentioned that Dr. Okun's center and Dr. Greenberg have received funding from Medtronic. Greenberg's current funding from the National Institute of Mental Health was noted. We think the sourcing and disclosure was adequate. A strong point of the story was that it repeatedly provided the context for the use of deep brain stimulation "when standard medications failworst-case patientsdoesn't mean patients can abandon traditional therapypeople with intractable (problems)(people who) failed behavior therapy." This story already attempted to accomplish a lot, but to be complete, it could have offered explicit description of currently approved options: antidepressant medications (multiple classes); psychotherapy (multiple options); combinations of medications or medications and therapy; transcranial magnetic stimulation (limited availabilty), vagal nerve stimulation, ECT and estimate of the proportion of patients who fail these treatments. Nonethless, we feel it met the criteria for a satisfactory score. The story states that 70,000 have had deep brian stimulation for Parkinson's or other movement disorders, and that studies are underway on at least 60 people with intractable obsessive-compulsive disorder and 100 with severe depression. The experimental nature of these approaches is clear from the story. A nice touch would be to give a link to clinicaltrials.gov to allow readers the option of looking up more information on the studies in progress and finding out if recruitment is open and how to access the study. The story did a good job putting the new uses of deep brain stimulation into the context of other research and other therapeutic approaches. It's clear that the story did not rely on a news release. Claim: Trying brain pacemakers to zap psychiatric disease

Answer: We especially appreciate the lack of hype in this story. The reporter clearly worked hard to stick to the evidence not merely to promote the potential. About 65-70 percent of patients with major depressive disorder improve substantially with 1 to 2 course of standard treatment (medication, psychotherapy or combinations). Subsequent treatment options have progressively lower rates of treatment response. Therefore, a significant number of people need other treatment options. Deep brain stimulation is an invasive treatment, but one that has shown promise in a small number of patients.

Question: Paragraph: U.S. Marines of Weapons Company, 1st Battalion, 3rd Marines are silhouetted against the sunset during a joint patrol with Afghan National Army (ANA) soldiers along Helmand river near the Camp Gorgak in Helmand province, southern Afghanistan, July 3, 2011. REUTERS/Shamil Zhumatov The study, published in the Archives of Pediatrics and Adolescent Medicine, analyzed medical records of 307,520 children of active-duty Army personnel, aged 5 to 17 years old. It found almost 17 percent of them exhibited mental health problems. "Children of parents who spent more time deployed between 2003 and 2006 fared worse than children whose parents were deployed for a shorter duration," the study's researchers wrote. The lead researcher was Alyssa Mansfield, who was at the University of North Carolina at Chapel Hill at the time the study was conducted. The U.S. Army reported some 562,000 members in active duty and more than 570,000 children of such members in 2010. Just under two-thirds of all active-duty servicemen and women were married and 15 percent were raising children as single parents. The children whose parents deployed at least once, for an average of 11 months, as part of the U.S. Operation Iraqi Freedom or Operation Enduring Freedom in Afghanistan were especially likely to suffer from adjustment, behavioral, depressive or stress disorders than those whose parents never went to war, the study found. Boys were more likely to have mental health problems than girls, according to the report, which reviewed records for patients cared for at military medical facilities and at civilian facilities using military medical insurance. "We used to think about deployment as a single experience: I go, I'm away, it's difficult and then I come back. Well, it's a way of life in the military that deployments continue to occur and families have to manage the consequences," said Dr. Stephen Cozza, psychiatry professor at the Uniformed Services University of the Health Sciences. Cozza has studied the issue and wrote an editorial accompanying the report. "These are consequences that aren't necessarily short-term," he said. The challenges don't necessarily end with the final return home, he said, as soldiers may bring back their own mental health issues which affect relationships with their children. Claim: Mental problems of soldiers' kids tied to wars.

Answer: The longer U.S. soldiers were deployed in Iraq or Afghanistan, the more likely their children would be diagnosed with mental health problems, according to a study published Monday.

Question: Paragraph: The coronavirus has infected more than 168,000 people worldwide and killed at least 6,610, according to the World Health Organization (WHO). While the bulk of those infected experience only mild symptoms, it is severe or critical in 20% of patients. The virus mortality rate is about 3.4%, the WHO has estimated. As scientists scramble to develop a vaccine, researchers at Australia's Peter Doherty Institute for Infection and Immunity said they had taken an important step in understanding the virus. By examining the blood results from an unidentified woman in her 40s, they discovered that people's immune systems respond to coronavirus in the same way it typically fights flu. The findings help scientists understand why some patients recover while others develop more serious respiratory problems, the researchers said. "People can use our methods to understand the immune responses in larger COVID-19 cohorts, and also understand what's lacking in those who have fatal outcomes," said Katherine Kedzierska, professor of microbiology and immunology at the University of Melbourne, which took part in the research. COVID-19 is the disease caused by the coronavirus. As researchers monitored the Australian patient's immune response, they were able to accurately predict when she would recover. Researchers did not name the patient, but said she was an Australian citizen who was evacuated out of Wuhan, the epicentre of the coronavirus outbreak in China. Health Minister Greg Hunt described the development as "world leading" and a major development in research on the disease. "It's about fast-tracking a vaccine by identifying which candidates are most likely to be successful," Hunt told reporters. "It's also about fast-tracking potential therapies and treatments for patients who already have coronavirus." At least a dozen drugmakers around the world are working on vaccines or antiviral and other treatments for the fast-spreading contagion. But investment costs for vaccines could run as high as $800 million in a process that, even if accelerated, will likely take more than a year until approval, according to executives from companies involved in the effort. Claim: Australian researchers map immune response to coronavirus.

Answer:
Australian researchers said on Tuesday they have mapped the immune responses from one of country's first coronavirus patients, findings the health minister said were an important step in developing a vaccine and treatment.